AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) EBIT

annual EBIT:

$12.28M+$86.98M(+116.44%)
December 31, 2024

Summary

  • As of today (July 26, 2025), AUPH annual earnings before interest & taxes is $12.28 million, with the most recent change of +$86.98 million (+116.44%) on December 31, 2024.
  • During the last 3 years, AUPH annual EBIT has risen by +$192.49 million (+106.82%).
  • AUPH annual EBIT is now at all-time high.

Performance

AUPH EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

quarterly EBIT:

$25.42M+$23.10M(+995.99%)
March 31, 2025

Summary

  • As of today (July 26, 2025), AUPH quarterly earnings before interest & taxes is $25.42 million, with the most recent change of +$23.10 million (+995.99%) on March 31, 2025.
  • Over the past year, AUPH quarterly EBIT has increased by +$34.14 million (+391.23%).
  • AUPH quarterly EBIT is now at all-time high.

Performance

AUPH quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

TTM EBIT:

$46.43M+$34.14M(+277.97%)
March 31, 2025

Summary

  • As of today (July 26, 2025), AUPH TTM earnings before interest & taxes is $46.43 million, with the most recent change of +$34.14 million (+277.97%) on March 31, 2025.
  • Over the past year, AUPH TTM EBIT has increased by +$104.08 million (+180.53%).
  • AUPH TTM EBIT is now at all-time high.

Performance

AUPH TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AUPH EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+116.4%+391.2%+180.5%
3 y3 years+106.8%+167.1%+127.7%
5 y5 years+113.5%+201.1%+140.5%

AUPH EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+106.8%at high+171.6%at high+129.8%
5 y5-yearat high+106.8%at high+150.3%at high+125.8%
alltimeall timeat high+106.8%at high+150.3%at high+125.8%

AUPH EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$25.42M(+996.0%)
$46.43M(+278.0%)
Dec 2024
$12.28M(-116.4%)
$2.32M(-85.5%)
$12.28M(-181.1%)
Sep 2024
-
$16.02M(+498.5%)
-$15.14M(-64.7%)
Jun 2024
-
$2.68M(-130.7%)
-$42.91M(-25.6%)
Mar 2024
-
-$8.73M(-65.2%)
-$57.65M(-22.8%)
Dec 2023
-$74.69M(-29.8%)
-$25.11M(+113.7%)
-$74.69M(-0.1%)
Sep 2023
-
-$11.75M(-2.7%)
-$74.78M(+5.2%)
Jun 2023
-
-$12.07M(-53.2%)
-$71.06M(-24.8%)
Mar 2023
-
-$25.77M(+2.3%)
-$94.50M(-11.4%)
Dec 2022
-$106.35M(-41.0%)
-$25.19M(+213.5%)
-$106.61M(-6.1%)
Sep 2022
-
-$8.04M(-77.4%)
-$113.60M(-27.1%)
Jun 2022
-
-$35.51M(-6.3%)
-$155.92M(-6.9%)
Mar 2022
-
-$37.88M(+17.7%)
-$167.54M(-7.0%)
Dec 2021
-$180.21M(+72.8%)
-$32.18M(-36.1%)
-$180.21M(+15.5%)
Sep 2021
-
-$50.35M(+6.8%)
-$156.08M(+5.4%)
Jun 2021
-
-$47.13M(-6.7%)
-$148.04M(+15.9%)
Mar 2021
-
-$50.54M(+527.7%)
-$127.77M(+24.8%)
Dec 2020
-$104.29M(+14.7%)
-$8.05M(-81.0%)
-$102.37M(-25.8%)
Sep 2020
-
-$42.31M(+57.5%)
-$137.98M(+20.3%)
Jun 2020
-
-$26.86M(+6.8%)
-$114.67M(+10.6%)
Mar 2020
-
-$25.14M(-42.4%)
-$103.68M(+14.0%)
Dec 2019
-$90.94M(+62.7%)
-$43.66M(+129.8%)
-$90.94M(+69.5%)
Sep 2019
-
-$19.00M(+19.7%)
-$53.66M(+1.2%)
Jun 2019
-
-$15.88M(+28.0%)
-$53.00M(+0.3%)
Mar 2019
-
-$12.40M(+94.5%)
-$52.83M(-5.5%)
Dec 2018
-$55.91M(+18.8%)
-$6.38M(-65.2%)
-$55.91M(-9.3%)
Sep 2018
-
-$18.34M(+16.8%)
-$61.67M(+8.0%)
Jun 2018
-
-$15.71M(+1.5%)
-$57.12M(+11.0%)
Mar 2018
-
-$15.48M(+27.5%)
-$51.46M(+9.3%)
Dec 2017
-$47.06M(+106.3%)
-$12.14M(-12.0%)
-$47.06M(+9.6%)
Sep 2017
-
-$13.79M(+37.2%)
-$42.95M(+24.3%)
Jun 2017
-
-$10.05M(-9.3%)
-$34.55M(+18.9%)
Mar 2017
-
-$11.09M(+38.1%)
-$29.05M(+27.3%)
Dec 2016
-$22.81M(-3.2%)
-$8.03M(+48.9%)
-$22.81M(+12.3%)
Sep 2016
-
-$5.39M(+18.4%)
-$20.31M(-4.9%)
Jun 2016
-
-$4.55M(-6.1%)
-$21.35M(-6.6%)
Mar 2016
-
-$4.85M(-12.3%)
-$22.85M(-3.1%)
Dec 2015
-$23.58M(+21.6%)
-$5.52M(-14.1%)
-$23.58M(-9.9%)
Sep 2015
-
-$6.43M(+6.2%)
-$26.16M(+71.0%)
Jun 2015
-
-$6.05M(+8.5%)
-$15.29M(-24.6%)
Mar 2015
-
-$5.58M(-31.2%)
-$20.28M(+4.3%)
Dec 2014
-$19.39M(+199.7%)
-$8.11M(-282.6%)
-$19.45M(+49.5%)
Sep 2014
-
$4.44M(-140.2%)
-$13.01M(-36.7%)
Jun 2014
-
-$11.03M(+132.5%)
-$20.54M(+96.5%)
Mar 2014
-
-$4.75M(+184.5%)
-$10.45M(+61.6%)
Dec 2013
-$6.47M(-33.2%)
-$1.67M(-46.1%)
-$6.47M(-34.9%)
Sep 2013
-
-$3.10M(+227.2%)
-$9.94M(+16.3%)
Jun 2013
-
-$946.00K(+24.3%)
-$8.55M(-13.7%)
Mar 2013
-
-$761.00K(-85.2%)
-$9.91M(+3.2%)
Dec 2012
-$9.68M(+302.3%)
-$5.14M(+202.1%)
-$9.60M(+294.8%)
Sep 2012
-
-$1.70M(-26.1%)
-$2.43M(+32.3%)
Jun 2012
-
-$2.30M(+408.3%)
-$1.84M(-134.4%)
Mar 2012
-
-$453.00K(-122.4%)
$5.34M(+33.5%)
DateAnnualQuarterlyTTM
Dec 2011
-$2.41M(-55.2%)
$2.03M(-282.9%)
$4.00M(-985.9%)
Sep 2011
-
-$1.11M(-122.7%)
-$451.80K(-39.4%)
Jun 2011
-
$4.88M(-372.1%)
-$745.00K(-88.0%)
Mar 2011
-
-$1.79M(-26.2%)
-$6.22M(+15.9%)
Dec 2010
-$5.37M(-28.5%)
-$2.43M(+73.2%)
-$5.37M(+120.4%)
Sep 2010
-
-$1.40M(+132.6%)
-$2.44M(-18.5%)
Jun 2010
-
-$602.40K(-35.9%)
-$2.99M(-39.2%)
Mar 2010
-
-$939.80K(-285.6%)
-$4.92M(-27.5%)
Dec 2009
-$7.51M(-51.9%)
$506.40K(-125.9%)
-$6.78M(-22.4%)
Sep 2009
-
-$1.95M(-22.9%)
-$8.74M(-17.2%)
Jun 2009
-
-$2.53M(-9.6%)
-$10.55M(-22.4%)
Mar 2009
-
-$2.80M(+93.3%)
-$13.59M(-14.9%)
Dec 2008
-$15.62M(-56.5%)
-$1.45M(-61.5%)
-$15.97M(-32.1%)
Sep 2008
-
-$3.77M(-32.4%)
-$23.51M(-15.7%)
Jun 2008
-
-$5.57M(+7.4%)
-$27.90M(-13.1%)
Mar 2008
-
-$5.19M(-42.3%)
-$32.09M(-5.6%)
Dec 2007
-$35.88M(+48.6%)
-$8.98M(+10.1%)
-$33.98M(+9.2%)
Sep 2007
-
-$8.16M(-16.5%)
-$31.11M(+5.0%)
Jun 2007
-
-$9.76M(+38.0%)
-$29.63M(+13.7%)
Mar 2007
-
-$7.08M(+15.7%)
-$26.06M(+9.2%)
Dec 2006
-$24.15M(-20.3%)
-$6.12M(-8.4%)
-$23.87M(-7.5%)
Sep 2006
-
-$6.67M(+7.8%)
-$25.81M(-1.9%)
Jun 2006
-
-$6.19M(+26.7%)
-$26.30M(-2.8%)
Mar 2006
-
-$4.89M(-39.3%)
-$27.07M(-8.3%)
Dec 2005
-$30.29M(+30.8%)
-$8.06M(+12.4%)
-$29.51M(-2.2%)
Sep 2005
-
-$7.17M(+3.0%)
-$30.16M(+1.7%)
Jun 2005
-
-$6.96M(-4.9%)
-$29.67M(+11.1%)
Mar 2005
-
-$7.32M(-15.9%)
-$26.70M(+17.2%)
Dec 2004
-$23.16M(+106.5%)
-$8.71M(+30.5%)
-$22.79M(+17.5%)
Sep 2004
-
-$6.68M(+67.3%)
-$19.39M(+15.1%)
Jun 2004
-
-$3.99M(+17.1%)
-$16.85M(+97.5%)
Mar 2004
-
-$3.41M(-35.8%)
-$8.53M(+2.1%)
Dec 2003
-$11.22M(+627.0%)
-$5.31M(+28.3%)
-$8.36M(+36.1%)
Sep 2003
-
-$4.14M(-195.7%)
-$6.14M(+2195.4%)
Jun 2003
-
$4.33M(-233.8%)
-$267.50K(-88.4%)
Mar 2003
-
-$3.24M(+4.6%)
-$2.30M(+61.1%)
Dec 2002
-$1.54M(-79.5%)
-$3.09M(-278.4%)
-$1.43M(-186.0%)
Sep 2002
-
$1.73M(-24.4%)
$1.66M(-167.6%)
Jun 2002
-
$2.29M(-197.0%)
-$2.46M(-69.3%)
Mar 2002
-
-$2.36M(-1.1%)
-$8.00M(-24.0%)
Dec 2001
-$7.53M(+11.7%)
-
-
Aug 2001
-
-$2.39M(-26.6%)
-$10.53M(+8.0%)
May 2001
-
-$3.25M(+42.9%)
-$9.76M(+18.4%)
Feb 2001
-
-$2.28M(-13.0%)
-$8.24M(+21.3%)
Nov 2000
-$6.74M(+422.4%)
-$2.62M(+62.3%)
-$6.79M(+41.6%)
Aug 2000
-
-$1.61M(-7.1%)
-$4.80M(+47.5%)
May 2000
-
-$1.74M(+109.8%)
-$3.25M(+69.1%)
Feb 2000
-
-$827.00K(+33.1%)
-$1.92M(+48.5%)
Nov 1999
-$1.29M(-41.7%)
-$621.20K(+828.6%)
-$1.29M(+92.3%)
Aug 1999
-
-$66.90K(-83.6%)
-$672.70K(+11.0%)
May 1999
-
-$406.90K(+104.6%)
-$605.80K(+204.6%)
Feb 1999
-
-$198.90K
-$198.90K
Nov 1998
-$2.21M
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual EBIT year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly EBIT year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM EBIT year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual earnings before interest & taxes?

The current annual EBIT of AUPH is $12.28M

What is the all time high annual EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual earnings before interest & taxes is $12.28M

What is Aurinia Pharmaceuticals Inc. annual EBIT year-on-year change?

Over the past year, AUPH annual earnings before interest & taxes has changed by +$86.98M (+116.44%)

What is Aurinia Pharmaceuticals Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of AUPH is $25.42M

What is the all time high quarterly EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly earnings before interest & taxes is $25.42M

What is Aurinia Pharmaceuticals Inc. quarterly EBIT year-on-year change?

Over the past year, AUPH quarterly earnings before interest & taxes has changed by +$34.14M (+391.23%)

What is Aurinia Pharmaceuticals Inc. TTM earnings before interest & taxes?

The current TTM EBIT of AUPH is $46.43M

What is the all time high TTM EBIT for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM earnings before interest & taxes is $46.43M

What is Aurinia Pharmaceuticals Inc. TTM EBIT year-on-year change?

Over the past year, AUPH TTM earnings before interest & taxes has changed by +$104.08M (+180.53%)
On this page